31 Oct 2024
Edwards Lifesciences Response
1yThank you for sharing your insights. We are glad to hear that you value our competitive compensation, investment strategies, and the promising pipeline of new products. We acknowledge your comments regarding the complexities of our growth and the recent stock performance. Navigating these opportunities is a priority for us, and we remain committed to innovation and quality to help patients around the world.